CN104013682A - Traditional Chinese medicine antibacteria composition for inhibiting micrococcus luteus - Google Patents

Traditional Chinese medicine antibacteria composition for inhibiting micrococcus luteus Download PDF

Info

Publication number
CN104013682A
CN104013682A CN201410052640.7A CN201410052640A CN104013682A CN 104013682 A CN104013682 A CN 104013682A CN 201410052640 A CN201410052640 A CN 201410052640A CN 104013682 A CN104013682 A CN 104013682A
Authority
CN
China
Prior art keywords
silver
water
chinese medicine
extract
micrococcus luteus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410052640.7A
Other languages
Chinese (zh)
Other versions
CN104013682B (en
Inventor
许恒毅
熊勇华
王力均
郭亮
徐锋
万翠香
魏华
赖卫华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anxin Biotechnology Hunan Co ltd
Original Assignee
Nanchang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanchang University filed Critical Nanchang University
Publication of CN104013682A publication Critical patent/CN104013682A/en
Application granted granted Critical
Publication of CN104013682B publication Critical patent/CN104013682B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention discloses a traditional Chinese medicine antibacteria composition for inhibiting micrococcus luteus, and belongs to the traditional Chinese medicine field. A rheum officinale extracting solution and water-soluble nano-silver are mixed in the antibacteria composition in proportion, two medicines are synthesized to play the synergistic effect to inhibit the micrococcus luteus. Compared with the prior art, the antibacteria composition containing the rheum officinale extract and the nano-silver can solve the problem that the dosage of the rheum officinale bacteriostatic agent in the conventional antibacteria method is great; and meanwhile, the microorganism medicine resistance generating rate is reduced by adopting two antibacterial substances in low dosage, the toxicity to the human body is lowered, and the composition is safer.

Description

一种抑制藤黄微球菌的中药抑菌组合物A traditional Chinese medicine antibacterial composition for inhibiting Micrococcus luteus

技术领域 technical field

本发明属于中药领域,尤其涉及一种中药抑菌组合物。 The invention belongs to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine antibacterial composition.

背景技术 Background technique

大黄是多种蓼科大黄属的多年生植物的合称,也是中药材的名称。因其喜冷凉气候,且耐寒,故其主要生于山地林缘或草坡的阴湿环境,中药大黄具有攻积滞、清湿热、泻火、凉血、祛瘀、解毒等功效。现代药理研究证明,大黄具有抗菌作用,其中对于金黄色葡萄球菌、大肠杆菌、绿脓杆菌、伤寒沙门菌、痢疾杆菌、溶血性链球菌、肺炎球菌、白喉杆菌、炭疽杆菌、变形杆菌等都有较强的抑制作用,除此之外,还具有抗肿瘤、降低血压、健胃、利胆、保肝、强心、延缓衰老、调节免疫功能等作用。大黄因其具有较高的药用和保健价值,广泛引起了人们关注。 Rhubarb is a collective name for various perennial plants of the Polygonaceae Rhubarb genus, and it is also the name of Chinese medicinal materials. Because it likes a cool climate and is resistant to cold, it mainly grows in the damp environment on the edge of mountain forests or grass slopes. The traditional Chinese medicine rhubarb has the functions of attacking stagnation, clearing damp and heat, purging fire, cooling blood, removing blood stasis, and detoxifying. Modern pharmacological studies have proved that rhubarb has antibacterial effects, including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi, Shigella, hemolytic streptococcus, pneumococcus, diphtheria bacillus, Bacillus anthracis, Proteus, etc. Strong inhibitory effect, in addition, it also has the effects of anti-tumor, lowering blood pressure, invigorating the stomach, promoting gallbladder, protecting the liver, strengthening the heart, delaying aging, and regulating immune function. Rhubarb has attracted people's attention because of its high medicinal and health value.

中药制剂浓缩液制成口服液或抑菌剂、涂覆剂等一次用剂量大,且长期使用影响人体健康。 Concentrated Chinese medicine preparations made into oral liquids or antibacterial agents, coating agents, etc. have a large dosage at one time, and long-term use will affect human health.

发明内容 Contents of the invention

针对大黄抑菌剂一次用量大和长期使用影响人体健康问题,本发明人经过大量实验,发现纳米银能有效增强大黄提取液抑菌性能,减少大黄抑菌剂的用量,且采用两种低剂量的抑菌组合物,更加的安全。本发明的目的在于提供一种大黄纳米银抑菌组合物,减少大黄抑菌剂一次的用剂量和降低药品对人体的毒性。 Aiming at the large amount of rhubarb bacteriostatic agent once used and the long-term use affecting human health, the inventor found through a large number of experiments that nano-silver can effectively enhance the antibacterial performance of rhubarb extract, reduce the amount of rhubarb bacteriostatic agent, and use two low-dose The antibacterial composition is safer. The object of the present invention is to provide a rhubarb nano-silver bacteriostatic composition, which can reduce the once-used dose of rhubarb bacteriostatic agent and reduce the toxicity of medicine to human body.

本发明提供如下技术方案: The present invention provides following technical scheme:

一种抑菌组合物,含有大黄提取液、水溶性纳米银; An antibacterial composition, containing rhubarb extract and water-soluble nano-silver;

大黄提取液制备包括如下步骤:加水量为大黄重量的9倍,经95 ℃水浴提取4 h,再经过减压浓缩得到提取液。所得提取液经0.22 μm滤膜过滤。最后提取液经高效液相色谱法对大黄素进行标准定量。 The preparation of the rhubarb extract includes the following steps: adding 9 times the weight of rhubarb, extracting in a water bath at 95 °C for 4 h, and then concentrating under reduced pressure to obtain the extract. The obtained extract was filtered through a 0.22 μm membrane filter. Finally, the extract was subjected to standard quantification of emodin by high performance liquid chromatography.

水溶性纳米银颗粒粒径为3~10 nm,纳米银外表包覆两性聚合物。 The particle size of the water-soluble nano-silver particles is 3-10 nm, and the surface of the nano-silver is coated with an amphoteric polymer.

水溶性纳米银粒径为3~10 nm,外表为羧基,依照下列方法制备:取22.8 g十四烷酸溶于140 mL按2:5比例混合的甲醇和水中,向溶液中加入4 g的氢氧化钠析出沉淀,过滤,将沉淀加入到100 mL浓度为10 mol/L水溶性的硝酸银溶液中得到十四烷酸银;称取6.7 g 浓度为20 mmoL/L 十四烷酸银于100 mL烧杯中,向烧杯中加入58 mL浓度为40 mmoL/L的三乙胺,80℃下电磁搅拌2 h,白色的十四烷酸银粉末逐渐变成棕色,不溶的前体消失,加入20 mL丙酮沉淀析出,抽滤,用丙酮洗涤沉淀数次后,真空干燥,即得到纳米银粒子粉末。依照本方法制备的水溶性纳米银颗粒与大黄提取液具有良好的的协同抗菌作用。 The particle size of water-soluble nano-silver is 3-10 nm, and the appearance is carboxyl group. It is prepared according to the following method: take 22.8 g of myristic acid and dissolve it in 140 mL of methanol and water mixed in a ratio of 2:5, and add 4 g of Sodium hydroxide precipitates, filters, and the precipitate is added to 100 mL of 10 mol/L water-soluble silver nitrate solution to obtain silver myristate; 6.7 g of 20 mmoL/L silver myristate is weighed in In a 100 mL beaker, add 58 mL of triethylamine with a concentration of 40 mmoL/L to the beaker, and stir it electromagnetically for 2 h at 80 °C. The white silver myristate powder gradually turns brown, and the insoluble precursor disappears. Add 20 mL of acetone was precipitated, filtered by suction, washed with acetone several times, and dried in vacuum to obtain nano-silver particle powder. The water-soluble nano-silver particle prepared according to the method has good synergistic antibacterial effect with rhubarb extract.

抑制大肠杆菌O157:H7时大黄提取液、水溶性纳米银的体积比为 75~100:1 When inhibiting Escherichia coli O157:H7, the volume ratio of rhubarb extract and water-soluble nano-silver is 75-100:1

抑制藤黄微球菌时大黄提取液、水溶性纳米银的体积比为和25~50:1。 When inhibiting Micrococcus luteus, the volume ratio of rhubarb extract and water-soluble nano-silver is 25-50:1.

本发明还涉及上述抑菌组合物在抑制大肠杆菌O157:H7中的应用。 The present invention also relates to the application of the above antibacterial composition in inhibiting Escherichia coli O157:H7.

本发明还涉及上述抑菌组合物在抑制藤黄微球菌中的应用   The present invention also relates to the application of the above antibacterial composition in inhibiting Micrococcus luteus

本发明的有益效果是:水溶性纳米银的应用能有效增强大黄抑菌性能,降低大黄抑菌剂的用量,令人意向不到的是,两种药物的合用对抑制大肠杆菌O157:H7和藤黄微球菌起到协同作用,同时本抑菌组合物采用两种低剂量的抑菌物质,相对于使用高剂量的大黄或者水溶性纳米银,更加的安全,可以作为安全可靠地外用涂覆剂等。 The beneficial effects of the present invention are: the application of water-soluble nano-silver can effectively enhance the rhubarb bacteriostatic performance, reduce the consumption of rhubarb bacteriostatic agents, and what is unexpected is that the combined use of two kinds of medicines can inhibit Escherichia coli O157:H7 and Micrococcus luteus plays a synergistic effect. At the same time, the antibacterial composition uses two low-dose antibacterial substances, which is safer than the use of high-dose rhubarb or water-soluble nano-silver, and can be used as a safe and reliable external coating agent etc.

附图说明 Description of drawings

图1大黄提取液与纳米银之比为100:1对大肠杆菌O157:H7协同抑菌作用 Figure 1 The ratio of rhubarb extract to nano-silver is 100:1 for synergistic antibacterial effect on Escherichia coli O157:H7

图1a 200 μL大黄提取液对大肠杆菌O157:H7的抑制作用,图1b 2 μL的纳米银对大肠杆菌O157:H7的抑制作用,图1c 100 μL大黄提取液与1 μL纳米银对大肠杆菌O157:H7的协同抑菌作用。 Figure 1a Inhibitory effect of 200 μL rhubarb extract on E. coli O157:H7, Figure 1b Inhibition of 2 μL nano-silver on E. coli O157:H7, Figure 1c 100 μL rhubarb extract and 1 μL nano-silver on E. coli O157 : Synergistic antibacterial effect of H7.

图2大黄提取液与纳米银之比为75:1对大肠杆菌O157:H7协同抑菌作用 Figure 2 The ratio of rhubarb extract to nano-silver is 75:1 for synergistic antibacterial effect on Escherichia coli O157:H7

图2a 150 μL大黄提取液对大肠杆菌O157:H7的抑制作用,图2b 2 μL的纳米银对大肠杆菌O157:H7的抑制作用,图2c 75 μL大黄提取液和1 μL纳米银对大肠杆菌O157:H7的协同抑菌作用。 Figure 2a Inhibitory effect of 150 μL rhubarb extract on E. coli O157:H7, Figure 2b Inhibition of 2 μL nano-silver on E. coli O157:H7, Figure 2c 75 μL rhubarb extract and 1 μL nano-silver on E. coli O157 : Synergistic antibacterial effect of H7.

图3大黄提取液与纳米银之比为50:1对藤黄微球菌协同抑菌作用 Figure 3 The ratio of rhubarb extract to nano-silver is 50:1 for synergistic antibacterial effect on Micrococcus luteus

图3a 800 μL大黄提取液对藤黄微球菌的抑制作用,图3b 16 μL的纳米银对藤黄微球菌的抑制作用,图3c 400 μL大黄提取液和8 μL纳米银藤黄微球菌协同抑菌作用。 Figure 3a The inhibitory effect of 800 μL rhubarb extract on Micrococcus luteus, Figure 3b The inhibitory effect of 16 μL nano-silver on M. Bacteria.

图4大黄提取液与纳米银之比为25:1对藤黄微球菌协同抑菌作用 Figure 4 The ratio of rhubarb extract to nano-silver is 25:1 for synergistic antibacterial effect on Micrococcus luteus

图4a 400 μL大黄提取液对藤黄微球菌的抑制作用,图4b 16 μL的纳米银对藤黄微球菌的抑制作用,图4c 200 μL大黄提取液和8 μL纳米银藤黄微球菌协同抑菌作用。 Figure 4a The inhibitory effect of 400 μL rhubarb extract on M. luteus, Figure 4b The inhibitory effect of 16 μL nano-silver on M. Bacteria.

具体实施方式 Detailed ways

实施例1 Example 1

1、大黄提取液的制备过程: 1. The preparation process of rhubarb extract:

称取大黄50 g,加水量为450 mL,在95 ℃下提取4 h,经过真空旋转浓缩仪后,用0.22 μm滤膜除去提取液中的杂质和细菌,最后用高效液相色谱法测得提取液中大黄素含量为1.92 μg/g。 Weigh 50 g of rhubarb, add 450 mL of water, extract at 95 °C for 4 h, pass through a vacuum rotary concentrator, use a 0.22 μm filter to remove impurities and bacteria in the extract, and finally use high performance liquid chromatography to measure The emodin content in the extract was 1.92 μg/g.

2、水溶性银纳米颗粒制备 2. Preparation of water-soluble silver nanoparticles

取22.8 g十四烷酸溶于140 mL按2:5比例混合的甲醇和水中,向溶液中加入4 g的氢氧化钠析出沉淀,过滤,将沉淀加入到100 mL浓度为10 mol/L水溶性的硝酸银溶液中得到十四烷酸银;称取6.7 g 浓度为20 mmoL/L 十四烷酸银于100 mL烧杯中,向烧杯中加入58 mL浓度为40 mmoL/L的三乙胺,80℃下电磁搅拌2 h,白色的十四烷酸银粉末逐渐变成棕色,不溶的前体消失,加入20 mL丙酮沉淀析出,抽滤,用丙酮洗涤沉淀数次后,真空干燥,即得到纳米银粒子粉末。 Take 22.8 g of myristic acid and dissolve it in 140 mL of methanol and water mixed at a ratio of 2:5, add 4 g of sodium hydroxide to the solution to precipitate a precipitate, filter it, and add the precipitate to 100 mL of water-soluble solution with a concentration of 10 mol/L. Silver myristate was obtained from a neutral silver nitrate solution; 6.7 g of silver myristate with a concentration of 20 mmoL/L was weighed in a 100 mL beaker, and 58 mL of triethylamine with a concentration of 40 mmoL/L was added to the beaker , electromagnetically stirred at 80°C for 2 h, the white silver myristate powder gradually turned brown, and the insoluble precursor disappeared, and 20 mL of acetone was added to precipitate out, filtered by suction, washed with acetone for several times, and dried in vacuum. The nano silver particle powder is obtained.

3、大黄提取液与水溶性纳米银协同抑菌作用。 3. The synergistic antibacterial effect of rhubarb extract and water-soluble nano-silver.

a 、细菌的培养 a. Culture of bacteria

挑取LB琼脂培养基上的大肠杆菌O157:H7的单菌落于10 mL LB肉汤培养基中,置于37 ℃培养箱中培养16 h,再按1%的接种量接种于5 mL的LB肉汤培养基中,37 ℃培养4 h后。取1 mL上述菌液用0.1%的蛋白胨水连续稀释三个梯度,最终的菌液大约为106 CFU/mL。  Pick a single colony of Escherichia coli O157:H7 on LB agar medium, place it in 10 mL LB broth medium, culture it in a 37 °C incubator for 16 h, and then inoculate it into 5 mL LB at an inoculum size of 1%. After incubation in broth for 4 h at 37 °C. Take 1 mL of the above bacterial solution and serially dilute three gradients with 0.1% peptone water, and the final bacterial solution is about 10 6 CFU/mL.

b、水溶性纳米银与大黄提取液在抑菌性能上的协同作用 b. The synergistic effect of water-soluble nano-silver and rhubarb extract on antibacterial properties

分别取1 mL上述已稀释好的菌液于1.5 mL灭菌的离心管中,向1号离心管中分别加入200 μL大黄提取液(大黄素含量为1.92 μg/g,下同),向2号离心管中加入2 μL浓度为10 mg/mL的水溶性纳米银,向3号离心管中加入100 μL大黄提取液和1 μL浓度为10 mg/mL水溶性纳米银,4号离心管作为空白对照,不加入任何上述抑菌剂。为保证每管液体最终体积相等,差量用0.1%的蛋白胨水补齐,置于37℃摇床培养箱培养2 h。每组实验平行三次。 Take 1 mL of the above-mentioned diluted bacterial solution into 1.5 mL sterilized centrifuge tubes, respectively add 200 μL of rhubarb extract (emodin content is 1.92 μg/g, the same below) to No. 1 centrifuge tube, and add to 2 Add 2 μL of water-soluble nano-silver with a concentration of 10 mg/mL to No. 3 centrifuge tube, add 100 μL rhubarb extract and 1 μL of 10 mg/mL water-soluble nano-silver to No. Blank control, without adding any of the above antibacterial agents. In order to ensure that the final volume of each tube of liquid was equal, the difference was made up with 0.1% peptone water, and placed in a shaker incubator at 37°C for 2 h. Each experiment was performed in parallel three times.

c 、平板计数 c, plate count

将实验组待测液用PBS连续稀释两个梯度,100、10-1、10-2各取出200μL分别均匀涂布在 The solution to be tested in the experimental group was serially diluted in two gradients with PBS, and 200 μL of each of 10 0 , 10 -1 , and 10 -2 was taken out and spread evenly on the

LB固体平板上;空白组连续稀释四个梯度,从10-2、10-3、10-4三个梯度分别均涂布在LB On the LB solid plate; the blank group was serially diluted with four gradients, and the three gradients from 10 -2 , 10 -3 , and 10 -4 were all coated on LB

固体平板上。平板吹干后,37 ℃倒置培养12 h,长出菌落后计数,以30-300个菌落形成单 on a solid plate. After drying the plate, culture it upside down at 37°C for 12 hours, count the colonies after they grow out, and form a single colony with 30-300 colonies.

位(CFU)为有效的计数范围。每毫升原菌液活菌数=平板计数*稀释倍数*5 Bits (CFU) are valid counting ranges. The number of viable bacteria per milliliter of the original bacterial solution = plate count * dilution factor * 5

实验结果如下: The experimental results are as follows:

抑菌物质antibacterial substances 加入抑菌剂后能数出的菌落数The number of colonies that can be counted after adding the antibacterial agent 空白blank 6.5×107 CFU/mL6.5×10 7 CFU/mL 200 μL的大黄提取液200 μL of rhubarb extract 2.6×106 CFU/mL2.6×10 6 CFU/mL 含2 μL浓度为10 mg/mL的纳米银Contains 2 μL of silver nanoparticles at a concentration of 10 mg/mL 4.8×102 CFU/mL4.8×10 2 CFU/mL 含100 μL的大黄提取液与1μL浓度为10 mg/mL的纳米银Contains 100 μL of rhubarb extract and 1 μL of silver nanoparticles at a concentration of 10 mg/mL 0 CFU/mL0 CFU/mL

如图1所示,图1a 200 μL大黄提取液对大肠杆菌O157:H7的抑制作用,图1b 2 μL的纳米银对大肠杆菌O157:H7的抑制作用,图1c 100 μL大黄提取液与1 μL纳米银对大肠杆菌O157:H7的协同抑菌作用。 As shown in Figure 1, Figure 1a shows the inhibitory effect of 200 μL rhubarb extract on E. coli O157:H7, Figure 1b shows the inhibitory effect of 2 μL of nano-silver on E. Synergistic antibacterial effect of silver nanoparticles against Escherichia coli O157:H7.

实验表明:本发明提供的抑菌组合物具有减少大黄抑菌剂一次用量的作用,且两种药物的合用对抑制大肠杆菌O157:H7起到协同的作用。 Experiments show that the bacteriostatic composition provided by the invention has the effect of reducing the one-time dosage of rhubarb bacteriostatic agents, and the combination of the two drugs has a synergistic effect on inhibiting Escherichia coli O157:H7.

实施例2 Example 2

1、大黄提取液的制备过程: 1. The preparation process of rhubarb extract:

同实施例1。 With embodiment 1.

2、水溶性银纳米颗粒制备 2. Preparation of water-soluble silver nanoparticles

同实施例1。 With embodiment 1.

3、大黄提取液与水溶性纳米银协同抑菌作用。 3. The synergistic antibacterial effect of rhubarb extract and water-soluble nano-silver.

a 、细菌的培养 a. Culture of bacteria

挑取LB琼脂培养基上的大肠杆菌O157:H7的单菌落于10 mL LB肉汤培养基中,置于37 ℃培养箱中培养16 h,再按1%的接种量接种于5 mL的LB肉汤培养基中,37 ℃培养4 h后。取1 mL上述菌液用0.1%的蛋白胨水连续稀释三个梯度,最终的菌液大约为106 CFU/mL。  Pick a single colony of Escherichia coli O157:H7 on LB agar medium, place it in 10 mL LB broth medium, culture it in a 37 °C incubator for 16 h, and then inoculate it into 5 mL LB at an inoculum size of 1%. After incubation in broth for 4 h at 37 °C. Take 1 mL of the above bacterial solution and serially dilute three gradients with 0.1% peptone water, and the final bacterial solution is about 10 6 CFU/mL.

b、水溶性纳米银与大黄提取液在抑菌性能上的协同作用 b. The synergistic effect of water-soluble nano-silver and rhubarb extract on antibacterial properties

分别取1 mL上述已稀释好的菌液于1.5 mL灭菌的离心管中,向1号离心管中分别加入150 μL大黄提取液,向2号离心管中加入2 μL浓度为10 mg/mL的水溶性纳米银,向3号离心管中加入75 μL大黄提取液与1 μL浓度为10 mg/mL的水溶性纳米银,4号离心管作为空白对照,不加入任何上述抑菌剂。为保证每管液体最终体积相等,差量用0.1%的蛋白胨水补齐,置于37℃摇床培养箱培养2 h。每组实验平行三次。 Take 1 mL of the above-mentioned diluted bacterial solution in 1.5 mL sterilized centrifuge tubes, add 150 μL of rhubarb extract to No. 1 centrifuge tube, and add 2 μL of rhubarb extract to No. 75 μL of rhubarb extract and 1 μL of water-soluble nano-silver with a concentration of 10 mg/mL were added to No. 3 centrifuge tube, and No. 4 centrifuge tube was used as a blank control without adding any of the above antibacterial agents. In order to ensure that the final volume of each tube of liquid was equal, the difference was made up with 0.1% peptone water, and placed in a shaker incubator at 37°C for 2 h. Each experiment was performed in parallel three times.

c 、平板计数 c, plate count

将实验组待测液用PBS连续稀释两个梯度,100、10-1、10-2各取出200μL分别均匀涂布在 The solution to be tested in the experimental group was serially diluted in two gradients with PBS, and 200 μL of each of 10 0 , 10 -1 , and 10 -2 was taken out and spread evenly on the

LB固体平板上;空白组连续稀释四个梯度,从10-2、10-3、10-4三个梯度分别均涂布在LB On the LB solid plate; the blank group was serially diluted with four gradients, and the three gradients from 10 -2 , 10 -3 , and 10 -4 were all coated on LB

固体平板上。平板吹干后,37 ℃倒置培养12 h,长出菌落后计数,以30-300个菌落形成单 on a solid plate. After drying the plate, culture it upside down at 37°C for 12 hours, count the colonies after they grow out, and form a single colony with 30-300 colonies.

位(CFU)为有效的计数范围。每毫升原菌液活菌数=平板计数*稀释倍数*5 Bits (CFU) are valid counting ranges. The number of viable bacteria per milliliter of the original bacterial solution = plate count * dilution factor * 5

实验结果如下: The experimental results are as follows:

抑菌物质antibacterial substances 加入抑菌剂后能数出的菌落数The number of colonies that can be counted after adding the antibacterial agent 空白blank 5.7×106 CFU/mL5.7×10 6 CFU/mL 150 μL的大黄提取液150 μL of rhubarb extract 2.6×106 CFU/mL2.6×10 6 CFU/mL 含2 μL浓度为10 mg/mL的纳米银Contains 2 μL of silver nanoparticles at a concentration of 10 mg/mL 4.8×102 CFU/mL4.8×10 2 CFU/mL 含75 μL的大黄提取液、1 μL浓度为10 mg/mL的纳米银溶液Contains 75 μL rhubarb extract, 1 μL nano-silver solution with a concentration of 10 mg/mL 200 CFU/mL200 CFU/mL

如图2所示,图2a 150 μL大黄提取液对大肠杆菌O157:H7的抑制作用,图2b 2 μL的纳米银对大肠杆菌O157:H7的抑制作用,图2c 75 μL大黄提取液和1 μL纳米银对大肠杆菌O157:H7的协同抑菌作用。 As shown in Figure 2, Figure 2a shows the inhibitory effect of 150 μL rhubarb extract on E. coli O157:H7, Figure 2b shows the inhibitory effect of 2 μL of nano-silver on E. Synergistic antibacterial effect of silver nanoparticles against Escherichia coli O157:H7.

实验表明:本发明提供的抑菌组合物具有减少大黄抑菌剂一次用量的作用,且两种药物的合用对抑制大肠杆菌O157:H7起到协同的作用。 Experiments show that the bacteriostatic composition provided by the invention has the effect of reducing the one-time dosage of rhubarb bacteriostatic agents, and the combination of the two drugs has a synergistic effect on inhibiting Escherichia coli O157:H7.

实施例3 Example 3

1、大黄提取液的制备过程: 1. The preparation process of rhubarb extract:

同实施例1。 With embodiment 1.

2、水溶性银纳米颗粒制备 2. Preparation of water-soluble silver nanoparticles

同实施例1。 With embodiment 1.

3、大黄提取液与水溶性纳米银协同抑菌作用。 3. The synergistic antibacterial effect of rhubarb extract and water-soluble nano-silver.

a 、细菌的培养 a. Culture of bacteria

挑取牛肉膏蛋白胨琼脂培养基上的藤黄微球菌单菌落于5 mL 牛肉膏蛋白胨液体培养基中,置于30 ℃培养箱中培养24 h,再按1%的接种量接种于5 mL的牛肉膏蛋白胨液体培养基中,30 ℃培12 h后。取1 mL上述菌液在用PBS与液体培养基按4:1比例混合的混合液中连续稀释三个梯度,最终的菌液大约为106~107 CFU/mL。 Pick a single colony of Micrococcus luteus on the beef extract-peptone agar medium and put it in 5 mL of beef extract-peptone liquid medium, culture it in a 30 °C incubator for 24 h, and then inoculate it in 5 mL of After cultured in beef extract peptone liquid medium at 30 °C for 12 h. Take 1 mL of the above bacterial solution and serially dilute three gradients in the mixture of PBS and liquid medium at a ratio of 4:1, and the final bacterial solution is about 10 6 -10 7 CFU/mL.

b、水溶性纳米银与大黄提取液在抑菌性能上的协同作用 b. The synergistic effect of water-soluble nano-silver and rhubarb extract on antibacterial properties

分别取1 mL上述已稀释好的菌液于1.5 mL灭菌的离心管中,向1号离心管中分别加入800 μL大黄提取液(其中只加菌液500 μL),向2号离心管中加入16 μL浓度为10 mg/mL的水溶性纳米银,向3号离心管中加入400 μL大黄提取液和8 μL浓度为10 mg/mL的水溶性纳米银,4号离心管作为空白对照,不加入任何上述抑菌剂。为保证每管液体最终体积相等,差量用PBS与液体培养基按4:1比例混合的混合液补齐。置于30℃摇床培养箱培养6 h,每组实验平行三次。 Take 1 mL of the above-mentioned diluted bacterial solution into 1.5 mL sterilized centrifuge tubes, add 800 μL of rhubarb extract (500 μL of bacteria solution only) to No. 1 centrifuge tube, and add Add 16 μL of water-soluble nano-silver with a concentration of 10 mg/mL, add 400 μL of rhubarb extract and 8 μL of water-soluble nano-silver with a concentration of 10 mg/mL to No. 3 centrifuge tube, and No. 4 centrifuge tube as a blank control. Do not add any of the above bacteriostatic agents. In order to ensure that the final volume of each tube of liquid is equal, the difference is made up with a mixture of PBS and liquid medium at a ratio of 4:1. Placed in a shaker incubator at 30°C for 6 h, each experiment was repeated three times.

c 、平板计数 c, plate count

将实验组待测液用PBS连续稀释两个梯度,10-1、10-2、10-3各取出100μL分别均匀涂 The solution to be tested in the experimental group was serially diluted in two gradients with PBS, and 100 μL of each of 10 -1 , 10 -2 , and 10 -3 was taken out and spread evenly.

布在牛肉膏蛋白胨固体平板上;空白组连续稀释四个梯度,从10-2、10-3、10-4三个梯度分别均匀涂布在牛肉膏蛋白胨固体平板上。平板吹干后,30℃倒置培养48 h,长出菌落后计数,以20-200个菌落形成单位(CFU)为有效的计数范围。每毫升原菌液活菌数=平板计数*稀释倍数*10 Spread on the beef extract peptone solid plate; the blank group was serially diluted with four gradients, and spread evenly on the beef extract peptone solid plate respectively from three gradients of 10 -2 , 10 -3 , and 10 -4 . After drying the plate, culture it upside down at 30°C for 48 h, count the colonies after they grow out, and take 20-200 colony forming units (CFU) as the effective counting range. The number of viable bacteria per milliliter of original bacterial solution = plate count * dilution factor * 10

抑菌物质antibacterial substances 加入抑菌剂后能数出的菌落数The number of colonies that can be counted after adding the antibacterial agent 空白blank 1.4×107 CFU/mL1.4×10 7 CFU/mL 800 μL的大黄提取液800 μL of rhubarb extract 2.1×106 CFU/mL2.1×10 6 CFU/mL 含16 μL浓度为10 mg/mL的纳米银Contains 16 μL of silver nanoparticles at a concentration of 10 mg/mL 1.3×106 CFU/mL1.3×10 6 CFU/mL 含400 μL的大黄提取液与8μL浓度为10 mg/mL的纳米银Including 400 μL of rhubarb extract and 8 μL of silver nanoparticles at a concentration of 10 mg/mL 3.5×105 CFU/mL3.5×10 5 CFU/mL

如图3所示,图3a 800 μL大黄提取液对藤黄微球菌的抑制作用,图3b 16 μL的纳米银对藤黄微球菌的抑制作用,图3c 400 μL大黄提取液和8 μL纳米银藤黄微球菌协同抑菌作用。 As shown in Figure 3, Figure 3a shows the inhibitory effect of 800 μL rhubarb extract on M. Synergistic antibacterial effect of Micrococcus luteus.

实验表明:本发明提供的抑菌组合物具有减少大黄抑菌剂一次用量的作用,且两种药物的合用对抑制藤黄微球菌起到协同的作用。 Experiments show that the bacteriostatic composition provided by the invention has the effect of reducing the dosage of the rhubarb bacteriostatic agent at one time, and the combined use of the two drugs has a synergistic effect on inhibiting Micrococcus luteus.

实施例4 Example 4

1、大黄提取液的制备过程: 1. The preparation process of rhubarb extract:

同实施例1。 With embodiment 1.

2、水溶性银纳米颗粒制备 2. Preparation of water-soluble silver nanoparticles

同实施例1。 With embodiment 1.

4、大黄提取液与水溶性纳米银协同抑菌作用。 4. Synergistic antibacterial effect of rhubarb extract and water-soluble nano-silver.

a 、细菌的培养 a. Culture of bacteria

挑取牛肉膏蛋白胨琼脂培养基上的藤黄微球菌单菌落于5mL 牛肉膏蛋白胨液体培养基中,置于30 ℃培养箱中培养24 h,再按1%的接种量接种于5 mL的牛肉膏蛋白胨液体培养基中,30 ℃培12 h后。取1 mL上述菌液在用PBS与液体培养基按4:1比例混合的混合液中连续稀释三个梯度,最终的菌液大约为106~107 CFU/mL。 Pick a single colony of Micrococcus luteus on the peptone agar medium of beef extract and put it in 5 mL of peptone liquid medium of beef extract, culture it in a 30 °C incubator for 24 h, and then inoculate 5 mL of beef at an inoculation amount of 1%. Incubate peptone broth for 12 h at 30 °C. Take 1 mL of the above bacterial solution and serially dilute three gradients in the mixture of PBS and liquid medium at a ratio of 4:1, and the final bacterial solution is about 10 6 -10 7 CFU/mL.

b、水溶性纳米银与大黄提取液在抑菌性能上的协同作用 b. The synergistic effect of water-soluble nano-silver and rhubarb extract on antibacterial properties

分别取1 mL上述已稀释好的菌液于1.5 mL灭菌的离心管中,向1号离心管中分别加入400 μL大黄提取液,向2号离心管中加入16 μL浓度为10 mg/mL的水溶性纳米银,向3号离心管中加入200 μL大黄提取液和8 μL水溶性纳米银,4号离心管作为空白对照,不加入任何上述抑菌剂。为保证每管液体最终体积相等,差量用PBS与液体培养基按4:1比例混合的混合液补齐。置于30℃摇床培养箱培养6 h,每组实验平行三次。 Take 1 mL of the above-mentioned diluted bacterial solution in 1.5 mL sterilized centrifuge tubes, add 400 μL of rhubarb extract to No. 1 centrifuge tube, and add 16 μL of rhubarb extract to No. 200 μL of rhubarb extract and 8 μL of water-soluble nano-silver were added to No. 3 centrifuge tube, and No. 4 centrifuge tube was used as a blank control without adding any of the above antibacterial agents. In order to ensure that the final volume of each tube of liquid is equal, the difference is made up with a mixture of PBS and liquid medium at a ratio of 4:1. Placed in a shaker incubator at 30°C for 6 h, each experiment was repeated three times.

c、平板计数 c. Plate count

将实验组待测液用PBS连续稀释两个梯度,10-1、10-2、10-3各取出100μL分别均匀涂 The solution to be tested in the experimental group was serially diluted in two gradients with PBS, and 100 μL of each of 10 -1 , 10 -2 , and 10 -3 was taken out and spread evenly.

布在牛肉膏蛋白胨固体平板上;空白组连续稀释四个梯度,从10-2、10-3、10-4三个梯度分别均匀涂布在牛肉膏蛋白胨固体平板上。平板吹干后,30℃倒置培养48 h,长出菌落后计数,以20-200个菌落形成单位(CFU)为有效的计数范围。每毫升原菌液活菌数=平板计数*稀释倍数*10 Spread on the beef extract peptone solid plate; the blank group was serially diluted with four gradients, and spread evenly on the beef extract peptone solid plate respectively from three gradients of 10 -2 , 10 -3 , and 10 -4 . After drying the plate, culture it upside down at 30°C for 48 h, count the colonies after they grow out, and take 20-200 colony forming units (CFU) as the effective counting range. The number of viable bacteria per milliliter of original bacterial solution = plate count * dilution factor * 10

抑菌物质antibacterial substances 加入抑菌剂后能数出的菌落数The number of colonies that can be counted after adding the antibacterial agent 空白blank 1.6×107 CFU/mL1.6×10 7 CFU/mL 400 μL的大黄提取液400 μL of rhubarb extract 2.6×106 CFU/mL2.6×10 6 CFU/mL 含16 μL浓度为10 mg/mL的纳米银Contains 16 μL of silver nanoparticles at a concentration of 10 mg/mL 1.54×106 CFU/mL1.54×10 6 CFU/mL 含200 μL的大黄提取液与8 μL浓度为10 mg/mL的纳米银Including 200 μL of rhubarb extract and 8 μL of silver nanoparticles at a concentration of 10 mg/mL 6.5×105 CFU/mL6.5×10 5 CFU/mL

如图4所示,图4a 400 μL大黄提取液对藤黄微球菌的抑制作用,图4b 16 μL的纳米银对藤黄微球菌的抑制作用,图4c 200 μL大黄提取液和8 μL纳米银藤黄微球菌协同抑菌作用。 As shown in Figure 4, Figure 4a shows the inhibitory effect of 400 μL rhubarb extract on M. luteus, Figure 4b shows the inhibitory effect of 16 μL of nano-silver on M. Synergistic antibacterial effect of Micrococcus luteus.

实验表明:本发明提供的抑菌组合物具有减少大黄抑菌剂一次用量的作用,且两种药物的合用对抑制藤黄微球菌起到协同的作用。 Experiments show that the bacteriostatic composition provided by the invention has the effect of reducing the dosage of the rhubarb bacteriostatic agent at one time, and the combined use of the two drugs has a synergistic effect on inhibiting Micrococcus luteus.

Claims (3)

1. a Chinese medicine bacteria inhibiting composition that suppresses micrococcus luteus, is characterized in that being comprised of Radix Et Rhizoma Rhei extract, water-soluble nano silver; Described Radix Et Rhizoma Rhei extract preparation comprises the steps: that amount of water is 9 times of Radix Et Rhizoma Rhei weight, extracts 4 h, then obtain extracting solution through concentrating under reduced pressure through 95 ℃ of water-baths; Described water-soluble nano silver is prepared according to following method: get 22.8 g tetradecanoic acids and be dissolved in 140 mL in the first alcohol and water of 2:5 ratio mixing, in solution, add the sodium hydroxide of 4 g to separate out precipitation, filter, it is to obtain tetradecanoic acid silver in the water miscible silver nitrate solution of 10 mol/L that precipitation is joined to 100 mL concentration; Taking 6.7 g concentration is that 20 mmoL/L tetradecanoic acid silver are in 100 mL beakers, to adding 58 mL concentration in beaker, it is the triethylamine of 40 mmoL/L, electromagnetic agitation 2 h at 80 ℃, the tetradecanoic acid silver powder of white becomes brown, insoluble disappearance gradually, adds 20 mL acetone precipitations to separate out, sucking filtration, with after washing with acetone precipitation several, vacuum drying, obtains nano silver particles powder; The volume ratio of Radix Et Rhizoma Rhei extract, water-soluble nano silver is and 25~50:1.
2. Chinese medicine bacteria inhibiting composition as claimed in claim 1, is characterized in that gained extracting solution is through 0.22 μ m membrane filtration.
3. as described in as arbitrary in claim 1 ~ 2, Chinese medicine bacteria inhibiting composition suppresses the application in micrococcus luteus medicine in preparation.
CN201410052640.7A 2012-09-28 2012-09-28 A kind of Traditional Chinese medicine bacteriostatic composition suppressing micrococcus luteus Expired - Fee Related CN104013682B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210366620.8A CN102895325B (en) 2012-09-28 2012-09-28 Traditional Chinese medicine bacteriostatic composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201210366620.8A Division CN102895325B (en) 2012-09-28 2012-09-28 Traditional Chinese medicine bacteriostatic composition

Publications (2)

Publication Number Publication Date
CN104013682A true CN104013682A (en) 2014-09-03
CN104013682B CN104013682B (en) 2015-11-25

Family

ID=47568011

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201410052640.7A Expired - Fee Related CN104013682B (en) 2012-09-28 2012-09-28 A kind of Traditional Chinese medicine bacteriostatic composition suppressing micrococcus luteus
CN201210366620.8A Expired - Fee Related CN102895325B (en) 2012-09-28 2012-09-28 Traditional Chinese medicine bacteriostatic composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201210366620.8A Expired - Fee Related CN102895325B (en) 2012-09-28 2012-09-28 Traditional Chinese medicine bacteriostatic composition

Country Status (1)

Country Link
CN (2) CN104013682B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016065609A1 (en) * 2014-10-31 2016-05-06 Kimberly-Clark Worldwide, Inc. Anti-adherent botanical compositions
US9969885B2 (en) 2014-07-31 2018-05-15 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
US10028899B2 (en) 2014-07-31 2018-07-24 Kimberly-Clark Worldwide, Inc. Anti-adherent alcohol-based composition
US10238107B2 (en) 2014-07-31 2019-03-26 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
US11168287B2 (en) 2016-05-26 2021-11-09 Kimberly-Clark Worldwide, Inc. Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface
US11737458B2 (en) 2015-04-01 2023-08-29 Kimberly-Clark Worldwide, Inc. Fibrous substrate for capture of gram negative bacteria
US12037497B2 (en) 2016-01-28 2024-07-16 Kimberly-Clark Worldwide, Inc. Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ201699A3 (en) * 2016-02-23 2017-04-12 Univerzita Tomáše Bati ve Zlíně Silver nanoparticles with improved properties, especially for environmentally friendly applications for sensors

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090260258A1 (en) * 2008-04-22 2009-10-22 Peter Spiegel Nano-silver footwear orthotic with insert and method of manufacture
KR20110031574A (en) * 2009-09-21 2011-03-29 전자부품연구원 Method for producing silver nanoparticles and silver nanoparticles accordingly
CN102416054A (en) * 2011-12-13 2012-04-18 成都默森医药开发有限公司 A composition for treating onychomycosis and tinea manus and pedis
CN102579982A (en) * 2012-03-05 2012-07-18 杨彦君 Externally-applied patch of for local point to treat gynecologic pelvic inflammatory disease and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101054444B1 (en) * 2008-11-13 2011-08-05 한국과학기술연구원 Continuous production method of surface-modified nanoparticles using supercritical fluid and surface-modified nanoparticles prepared by the method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090260258A1 (en) * 2008-04-22 2009-10-22 Peter Spiegel Nano-silver footwear orthotic with insert and method of manufacture
KR20110031574A (en) * 2009-09-21 2011-03-29 전자부품연구원 Method for producing silver nanoparticles and silver nanoparticles accordingly
CN102416054A (en) * 2011-12-13 2012-04-18 成都默森医药开发有限公司 A composition for treating onychomycosis and tinea manus and pedis
CN102579982A (en) * 2012-03-05 2012-07-18 杨彦君 Externally-applied patch of for local point to treat gynecologic pelvic inflammatory disease and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SANG MIN KIM ET AL: "Optimization of parameters for the synthesis of bimodal Ag nanoparticles", 《JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY》 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9969885B2 (en) 2014-07-31 2018-05-15 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
US10028899B2 (en) 2014-07-31 2018-07-24 Kimberly-Clark Worldwide, Inc. Anti-adherent alcohol-based composition
US10238107B2 (en) 2014-07-31 2019-03-26 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
US10292916B2 (en) 2014-07-31 2019-05-21 Kimberly-Clark Worldwide, Inc. Anti-adherent alcohol-based composition
WO2016065609A1 (en) * 2014-10-31 2016-05-06 Kimberly-Clark Worldwide, Inc. Anti-adherent botanical compositions
KR20170077132A (en) * 2014-10-31 2017-07-05 킴벌리-클라크 월드와이드, 인크. Anti-adherent botanical compositions
GB2547153A (en) * 2014-10-31 2017-08-09 Kimberly Clark Co Anti-adherent botanical compositions
GB2547153B (en) * 2014-10-31 2020-08-05 Kimberly Clark Co Anti-adherent botanical compositions
KR102291294B1 (en) 2014-10-31 2021-08-20 킴벌리-클라크 월드와이드, 인크. Anti-adherent botanical compositions
US11737458B2 (en) 2015-04-01 2023-08-29 Kimberly-Clark Worldwide, Inc. Fibrous substrate for capture of gram negative bacteria
US12037497B2 (en) 2016-01-28 2024-07-16 Kimberly-Clark Worldwide, Inc. Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface
US11168287B2 (en) 2016-05-26 2021-11-09 Kimberly-Clark Worldwide, Inc. Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface

Also Published As

Publication number Publication date
CN104013682B (en) 2015-11-25
CN102895325B (en) 2014-07-09
CN102895325A (en) 2013-01-30

Similar Documents

Publication Publication Date Title
CN102895325B (en) Traditional Chinese medicine bacteriostatic composition
CN110438091A (en) A new Klebsiella pneumoniae phage and its application
CN112245566B (en) New use of Scutellariae radix flavonoid and/or metal ion complexing agent in synergistic polymyxin antibiotic antibacterial effect
CN104147076B (en) Lonicera japonica antibacterial agent for restraining micrococcus luteus
CN111407817A (en) Traditional Chinese medicine composition for preventing respiratory tract infection pathogenic microorganisms and preparation method thereof
CN102895341B (en) Antibacterial Composition of Coptis Rhizoma Extract and Nano Silver
CN108686045B (en) A kind of naked flower purple pearl composition and its application in the treatment of pharyngitis
Yadav et al. In vitro Determination of Antibacterial Effect of Garlic (Allium sativum) on Staphylococcus aureus and E. coli
CN103848843B (en) Extraction method of active components of Artemisia annua and application of the components in resisting plant diseases
CN114931602A (en) A kind of Chinese herbal medicine formula for inhibiting dairy cow-derived Escherichia coli and preparation method thereof
CN102895282B (en) Isatis root extracting solution and nano-silver bacteriostatic composition
CN105963334A (en) Great burdock fruit extract and preparation method thereof and application of great burdock fruit extract in bacteriostasis
US20230405044A1 (en) Antiseptic composition
CN108853358A (en) A kind of antibacterial Chinese medicine composition and its preparation method and application
CN102895315B (en) A nano-silver antibacterial composition containing forsythia extract
CN110638985A (en) Chinese medicinal composition gel suppository for treating gynecological inflammation and preparation method thereof
CN109316533B (en) Fermented traditional Chinese medicine compound preparation for removing endotoxin in pig body and application thereof
CN108721167B (en) Preservative composition containing Ampelopsis grossedentata extract and application of preservative composition in preparation of cosmetics
CN103977028A (en) Antibacterial Composition of Sweet Potato Chlorogenic Acid and Nano Zinc Oxide
CN113318149A (en) Jasminum extract and preparation method and application thereof
CN114931599B (en) A composition for inhibiting Staphylococcus aureus biofilm and its preparation method
CN115154487B (en) Polysaccharide salt fog mixture containing probiotics fermentation liquor and used for protecting respiratory tract and application thereof
CN115501288B (en) Extraction method of callicarpa nudiflora extract and application of extract in resisting H1N1 virus
CN113546100B (en) Application of pachyrhizus extract in preparation of antibacterial product
CN110251538A (en) Application of Yaoyao rapeseed extract in preparation of medicine for treating pneumonia caused by Klebsiella infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20180726

Address after: 071000 No. 4, unit 20, 20 geophysical exploration complex, 168 Fuxing Road, Xushui, Baoding, Hebei.

Patentee after: Yin Liran

Address before: 330031 999, Xuefu Avenue, Nanchang, Jiangxi.

Patentee before: Nanchang University

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190129

Address after: 410300 No. 205 Luzhiyun Road, Liuyang Economic and Technological Development Zone, Hunan Province

Patentee after: Anxin Biotechnology (Hunan) Co.,Ltd.

Address before: 071000 No. 4, unit 20, 20 geophysical exploration complex, 168 Fuxing Road, Xushui, Baoding, Hebei.

Patentee before: Yin Liran

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151125

CF01 Termination of patent right due to non-payment of annual fee